Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: systematic literature review and analysis of a monocentric cohort
M Piga, E Chessa, V Ibba, V Mura, A Floris, A Cauli… - Autoimmunity …, 2014 - Elsevier
The use of biologic drugs has been linked with the paradoxical development of systemic and
organ specific autoimmune processes. The aim of this study was to describe the features of …
organ specific autoimmune processes. The aim of this study was to describe the features of …
Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties
E Chessa, M Piga, A Floris, H Devilliers, A Cauli… - …, 2020 - academic.oup.com
Objective The Physician Global Assessment (PGA) is a visual analogue score that reflects
the clinician’s judgement of overall SLE disease activity. The aim of this systematic literature …
the clinician’s judgement of overall SLE disease activity. The aim of this systematic literature …
[HTML][HTML] Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with …
M Piga, A Floris, G Cappellazzo, E Chessa… - Arthritis research & …, 2017 - Springer
Background The aim was to assess the attainability and outcome of the lupus low disease
activity state (LLDAS) in the early stages of systemic lupus erythematosus (SLE). Methods …
activity state (LLDAS) in the early stages of systemic lupus erythematosus (SLE). Methods …
[HTML][HTML] Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus
…, B Noli, M Congia, F Loy, M Isola, E Chessa… - Frontiers in …, 2023 - frontiersin.org
Introduction The pathogenesis of neuropsychiatric systemic lupus erythematosus (NPSLE)
is widely unknown, and the role of autoantibodies is still undetermined. Methods To identify …
is widely unknown, and the role of autoantibodies is still undetermined. Methods To identify …
Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic
Objective To evaluate the reliability of virtual video-assisted visits, added to the tight-control
strategy for inflammatory rheumatic diseases (IRDs), in identifying patients who need …
strategy for inflammatory rheumatic diseases (IRDs), in identifying patients who need …
[HTML][HTML] Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic …
A systematic review and meta-analysis were conducted, according to the PRISMA
methodology, to summarize current evidence on the prevalence and predictors of long-term …
methodology, to summarize current evidence on the prevalence and predictors of long-term …
Physician global assessment international standardisation consensus in systemic lupus erythematosus: the PISCOS study
The Physician Global Assessment International Standardisation COnsensus in Systemic
Lupus Erythematosus (PISCOS) study aimed to obtain an evidence-based and expert-based …
Lupus Erythematosus (PISCOS) study aimed to obtain an evidence-based and expert-based …
Demyelinating syndrome in SLE encompasses different subtypes: do we need new classification criteria? Pooled results from systematic literature review and …
M Piga, E Chessa, MT Peltz, A Floris, A Mathieu… - Autoimmunity …, 2017 - Elsevier
… Author links open overlay panel Matteo Piga a 1 , Elisabetta Chessa a 1 , Maria Teresa
Peltz b , Alberto Floris a , Alessandro Mathieu a , Alberto Cauli a …
Peltz b , Alberto Floris a , Alessandro Mathieu a , Alberto Cauli a …
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study
A Floris, E Chessa, GD Sebastiani, I Prevete… - RMD open, 2022 - rmdopen.bmj.com
Objective A subanalysis of the multicentre Early Lupus inception cohort was performed to
investigate the real-world Glucocorticoids (GCs) Use in newly diagnosed systemic lupus …
investigate the real-world Glucocorticoids (GCs) Use in newly diagnosed systemic lupus …
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series
E Chessa, M Piga, A Floris, A Mathieu, A Cauli - Reumatismo, 2017 - iris.unica.it
Demyelinating syndrome (DS) is a rare manifestation of systemic lupus erythematosus (SLE)(1%)
with high clinical heterogeneity and potentially severe prognosis. It can represent a …
with high clinical heterogeneity and potentially severe prognosis. It can represent a …